Skip to main navigation
Skip to content
Opiant_logo Opiant
Main Menu
  • Contact
  • Careers
  • About
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Addiction Disorders
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Acute Cannabinoid Overdose
    • Patients & Families
    • Scientific Publications
  • Products & Pipeline
    • Pipeline Chart
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News Releases
    • Events and Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financials & Filings
      • SEC Filings
      • Annual Reports & Proxy Statements

Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
May 26, 2020
Document Date
May 26, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Opiant Pharmaceuticals, Inc.
Issuer
Opiant Pharmaceuticals, Inc.
Filer
O'TOOLE DAVID D

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
RSS Feeds
Email Alerts
Contact IR

  • Privacy Policy
  • Site Map
© Opiant, 2021. All Rights Reserved.